InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: None

Tuesday, 11/10/2020 9:40:39 AM

Tuesday, November 10, 2020 9:40:39 AM

Post# of 403044
To those interested in yesterday's meeting with my friend and Dr. Ahmed. See below on their update.

Go Leo & IPIX!

Dr. Ahmed, a highly respected and experienced NY Pulmonologist, and who was personally engaged treating Covid-19 patients in NYC hospitals during the height of the Covid-19 crisis, was not aware of Brilacidin and has received Pre-Print Peer Review Article from GMU and other documents supporting Brilacidin as a potentially highly effective therapeutic. She was surprised to hear of Remdesivir/Brilacidin combo 100% (99.85%) viral reduction and will review all materials received.

information received included contact information to pursue additional DD with other MD's, PhD's etc.


Brilacidin In a human lung cell line infected by SARS-CoV-2, Brilacidin achieved a high Selectivity Index rating of 426.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News